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Abstract: Marketing and R&D strategies need to be aligned to increase the return from investment in new 
technologies. Various portfolio techniques have been widely used to support strategic planning. A new 
portfolio approach integrating market and technology portfolios to support market-oriented R&D planning is 
developed. The integrated portfolio is based on objective market and patent data and empirical evidence that 
the respective portfolio dimensions impact a company’s business performance. This contributes significantly 
to the relevance of the proposed integrated portfolio approach for strategic planning. It is tested in a practical 
application in the chemical industry. Based on these experiences, a set of recommendations for the effective 
use of the integrated portfolio for market-orientated strategic R&D planning is derived. 
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Introduction 
Market orientation is a key driver of company 
performance [1]. Accordingly, companies should 
align their core activities with market 
requirements. Among a company’s most important 
activities is the development and market 
introduction of new products because this 
determines sustained company success in many 
industries [2–4]. It has been frequently shown that 
the alignment of all process steps from idea to 
launch with market requirements is a success 
factor of new product development [5–7]. 
Consequently, research and development (R&D) 
should be focused on designing new products 
which satisfy market requirements. 
Technological change has been found to have a 
decisive impact on the competitive structure in 
many industries [8–10]. Thus, even if market 
requirements remain basically unchanged, 
technological progress can severely effect a 
company’s competitive position. These changes 
need to be identified and assessed as early as 
possible in order to align the firm’s R&D strategy 
accordingly [11–13]. Thus, market requirements 
and technological capabilities need to be assessed 
simultaneously in order to formulate effective 
strategies for new product development. 
It has been shown in empirical studies that the 
integration of market requirements and 
technological capabilities during new product 
development increases success [14,15]. At the 
same time, integration ought to be achieved also 
on the strategic level, i.e. Marketing and R&D 
strategy must be aligned [16]. There is empirical 
evidence that a strategy which balances market 
requirements and technology capabilities leads to 
higher new product success [17,18].  
The strategic management of a firm’s R&D 
portfolio enhances the success of new products 
[19]. To support strategic planning various 
portfolio concepts have been developed over the 
years. In the 1970s, market portfolios became 
popular to support strategic planning in large 
corporations. However, a product’s underlying 
technologies were not assessed in market 
portfolios which posed the danger to overlook 
technological changes and to make wrong 
investment decisions. Consequently, technology 
and patent portfolios were developed from the 
1980s onwards to assess technologies according to 
their competitive impact [11,20]. However, 
technology portfolios lack an explicit market 
focus. Thus, the need arises to integrate market 
and technology portfolios based on objective data 
in order to achieve a better alignment of Marketing 
and R&D strategies in companies. In this paper, 
we first develop such an integrated portfolio 
approach to support market-oriented R&D 
planning. Subsequently, we test the proposed 
portfolio method in a practical application. This 
paper concludes with an evaluation of the 
proposed portfolio method and with suggestions 
for further applications. 
Development of  an Integrated Portfolio 
Concept  
A  The Market Portfolio 
The concept of product portfolio analysis is 
one of the most widely used tools in the field of 
strategic planning. Its origins date back to the late 
sixties when diversified companies were facing an 
increasingly complex strategic planning process. 
Therefore, companies had to find new ways to 
assure an effective and efficient management of 
the company’s resources. The Boston Consulting 
Group developed its market share/market growth 
matrix for this purpose. It is still the most widely 
known and implemented approach [21,22]. It 
enables managers to easily comprehend and 
communicate a complex problem, thus having a 
powerful tool supporting strategic decision 
making. 
Subsequently many variants of this approach 
were developed, yet all varying the same basic 
structure [23]. All share a two dimensional 
framework with one dimension representing the 
competitive position in the respective market and 
the other one illustrating market attractiveness (see 
figure 1 for a depiction of a generic portfolio). The 
dimensions are either univariately or multivariately 
defined. The area spanned up by the dimensions is 
divided into four or more fields, each of them 
being assigned a generic strategic recommendation 
for the products or business units being positioned 
in the respective area. The size of the circles 
representing products or strategic business units is 
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usually determined by the respective share of sales 
or a measure of profitability. 
The market share/market growth approach is a 
sound concept regarding required data and 
underlying assumptions. It has been subject to 
much empirical research providing supporting 
evidence [24,25]. The required data is relatively 
easy to capture: market share and market growth 
can be objectively measured, the only problem 
being the correct definition of the relevant market 
[26]. 
However, critics quickly argued that the 
underlying assumptions are flawed. Indeed, there 
is empirical evidence that the relationship between 
market share and profitability is not as clear-cut as 
postulated in the generic strategies of the portfolio 
matrix [21]. Moreover, it is often argued that the 
data basis is too weak to make profound strategic 
decisions. This led to the development of product 
portfolio concepts using multivariate dimensions 
such as the market attractiveness/market position 
matrix developed by McKinsey [27]. In addition to 
market share, it uses a multitude of factors 
identified in the PIMS project, several of them 
qualitative and thus harder to measure. Their 
estimation may lead to biases due to the subjective 
nature of the respondent’s opinions.  
Thus, one faces a trade-off between a simple 
concept incorporating few variables, which can be 
objectively measured, or a complex model 
requiring data, which are hard to capture, thus 
leaving room for biases. When using the 
approaches based on few variables, it is important 
to keep in mind the limited data base of the 
simpler approaches, on which the generic 
strategies are recommended.  
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  Figure 1: A generic portfolio matrix. 
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Apart from these issues being more technical in 
nature, there is substantial criticism highlighting a 
central drawback of market portfolios. As they 
capture the market positioning of the company’s 
products or strategic business units and their 
respective current competitors, product portfolio 
analysis is essentially short-term oriented. It fails to 
capture external turbulences such as new 
technologies which affect the positioning in the 
portfolio and thus the recommended strategies.  
 
B The Technology Portfolio 
The Patent Portfolio 
Patent data and patent statistics have long been 
used by economists as a proxy for technological 
change and technological process. There is 
significant empirical evidence supporting the 
validity of this approach [28]. Patent data have the 
big advantage that they are widely available and 
objective in nature. In a further step, entire 
portfolios assessing a company’s patent position 
were proposed [29,30]. These assign the 
company’s patents to different technology fields 
relevant to the company and evaluate them 
afterwards using different indicators entirely based 
on patent data. The patent portfolio shares its 
basic structure with the technology portfolio, 
having one dimension assessing technological 
position and the other one assessing technology 
attractiveness. As patent portfolios (see figure 2) 
will be an important element of the integrated 
portfolio concepts developed later on in this 
article, we will briefly describe the indicators used 
to assess technological positions. For a more 
detailed description, please refer to the articles by 
Brockhoff and Ernst [29–31]. 
In analogy to the market growth/market share 
portfolio, it has been suggested to use the term 
‘relative technology share’ in order to describe the 
competitive technological position in analogy to 
‘relative market share’ commonly used to measure 
a firm’s competitive position in the market [32]. 
As this is a measure only incorporating 
patenting activity, but not accounting for the 
quality of patents, other operational definitions of 
the internal dimension have been proposed. 
Accounting for patent quality is an important link 
to establish an analogy between patent and market 
portfolios: both relative market share and relative 
technology share, incorporating patent quality, 
have a positive impact on a company’s business 
performance [33–36]. Therefore, a construct for 
patent quality consisting of different quality 
measures is used in newer approaches to assess the 
technological impact [37]: 
1. Rate of patents granted: A patent will be 
granted only if the invention consists of new and 
non-obvious technological elements. Thus, a 
patent is believed to have a higher technological 
Relative Technology Share
(Relative Patent Position)
highlow
high
low
Technology 
Attractiveness TFa
Importance of 
Technological Fields 
(R&D Emphasis): 
a (high) and b (low)
Investment
Selective Investment
Disinvestment
TFb
 
Figure 2: The patent portfolio. 
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value than the patent application [38]. The rate of 
patents granted substantially differ between 
companies and can thus serve as one indicator for 
the quality of research.  
2. International scope of patent applications: As 
the cost for obtaining valid patent for a number of 
countries is significantly higher than for a single 
national patent, the former have been empirically 
found to be of higher value than national 
applications only [28,37].  
3. Patent Citation Ratio: Patents are used by 
examiners at the patent office to document the 
state of technology when they check if a patent 
application contains new and inventive features 
which go beyond what has been known so far. 
This procedure leads to patent citations. The 
number of citations received by a patent in 
subsequent patent documents is often interpreted 
as a proxy for the economic importance of the 
invention [39–41].  
The use of different measures allows to achieve 
a stable assessment of a company’s patent position 
[31].  
The external dimension ‘technology 
attractiveness’, which is displayed on the ordinate, 
is measured by the growth rate, either absolute or 
relative,  of patent applications in the respective 
technology field. Using patent growth as a proxy 
for a technology’s attractiveness is supported by 
empirical studies showing a strong correlation 
between patent and market growth in various 
industries [12,37,42].  
The third dimension represented by the circle 
size of the technology fields in the patent portfolio 
is called ‘R&D emphasis’. It is calculated as the 
total number of patent applications of the 
company in one technology field divided by the 
total number of all patent applications of the 
respective company. Thus, “R&D emphasis” 
indicates a technology’s importance in the 
company’s total R&D portfolio. 
Generic strategies largely correspond to the 
generic strategies of the market growth/market 
share portfolio, e.g. to aggressively invest in 
technology fields with high growth and strong 
positions, i.e. high impact pacing and key 
technologies. Thus, the patent portfolio is the only 
technology portfolio grounded on a sound 
empirical basis.  
Despite this fact, patent portfolios share the 
most important drawback with classic technology 
portfolios. R&D planning is only one aspect of 
strategic planning. It necessarily leads to the 
misappropriation of resources if only technological 
aspects are considered in the planning process. 
Therefore, they need to be aligned with other 
strategic planning tools in order to avoid one-sided 
misconceptions.  
 
C The Integrated Portfolio  
Pure technology or market portfolios have a 
one-sided focus on either technology or product 
market. We already elaborated on the importance 
of market orientation in the R&D process. New 
technologies have to fulfil market needs. 
Otherwise products based on them will fail in the 
market. The integrated portfolio concepts trying to 
overcome this shortfall by combining market and 
technological analysis can be classified into three 
distinct groups: 
The first group builds upon an existing 
technology or market portfolio and adds generic 
strategies for the missing perspective [21,43]. 
Although this approach is intriguingly simple, it 
does not solve the central problem of 
incorporating the interdependencies. Applying 
similar strategic recommendations will only be 
valid if both technology and product are 
positioned in the same field of the portfolio. In all 
other cases, this will lead to a misallocation of 
resources and could even result in eroding the 
company’s competitive base. 
A second class of concepts develops entirely 
new portfolio approaches. Some of them use the 
classic matrix-type visualisation [44], while others 
follow different approaches for the formulation of 
the optimisation problem. Some approaches in the 
latter category use a mathematical formulation of 
the portfolio problem and usually have a very 
stringent general formulation [45]. Being often 
rather complex and thus difficult to communicate 
and implement, these approaches lack practical 
relevance as well. 
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The third group of concepts tries to aggregate 
two or more single portfolios into one holistic 
portfolio [11,46]. This could either be a new single 
matrix-type portfolio, i.e. a condensation of four 
dimension into only two. This procedure leads to a 
visualisation which is easy to understand and to 
communicate, but encounters several 
methodological problems. Another approach is the 
integration using a common axis. Generally, this 
type of integration is theoretically sound as no data 
are omitted and the original portfolios remain 
largely unchanged. Their added value is the 
development of new integrated generic strategies.  
Therefore, we will develop an integrated 
portfolio using this design, but following a more 
formalised approach to avoid the pitfalls of earlier 
concepts. Unlike other approaches, we will keep 
the amount of required data within reasonable 
limits in order to achieve an easy implementation 
while simultaneously building onto a theoretically 
sound basis. 
In the following, we introduce a framework for 
the creation of concepts for integrated portfolios 
and simultaneously develop a new portfolio. It 
draws on elements of a framework by 
Wind/Mahajan [27], however incorporates 
necessary changes for the formulation of an 
integrated portfolio concept (see figure 3). The 
process of developing our integrated portfolio 
concept follows these steps. First, the portfolios 
which are subsequently integrated into a single 
portfolio are identified. We already made a case for 
the use of patent portfolios instead of other 
technology portfolios, the biggest advantage being 
the sound empirical foundation and the objective 
data used by them. Therefore, a matching market 
portfolio, which captures the advantages of the 
patent portfolio, needs to be identified. The only 
market portfolio entirely relying on objective data 
is the market share/market growth matrix.  
In a second step, a suitable integration 
mechanism has to be found. In order to come up 
with an integrated portfolio which can be easily 
communicated, the integration using a common 
dimension is desirable. In order to emphasise the 
importance of market orientation in the R&D 
process, we suggest using market growth in the 
integrated portfolio. This approach clearly follows 
the notion that the attractiveness of a technology 
has to be mainly judged on the basis of its market 
impact. The growth/share matrix is now easy to 
integrate as both portfolios share a common 
dimension (see figure 4). In case a technology has 
not yet been integrated into products, we suggest 
to use the measure “patent growth” as described in 
the initial patent portfolio in order to capture the 
attractiveness of the technology (see figure 2). 
The third step is the inclusion of possible 
interdependencies between technologies and 
products into the analysis (see figure 4). The 
attractiveness of a technology field could be 
determined by the weighted average of the market 
growth rate of the products in which the 
technology field is applied. Weights could be 
defined as the share of one product’s contribution 
to the total sales generated by all products 
incorporating the respective technology.  
Alternatively, a similar measure could be based 
on profit data. This way, all interdependencies 
between technologies and products can be 
captured. To assess new technologies not yet 
incorporated in existing products, we suggest using 
expert assessments to compensate for eventually 
missing quantitative market data. 
 
 
 
 
 
Selection of the single portfolios to be
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Analysis of the portfolio concepts:
Combination of technology and
products/SGEs
Identification of the optimal method for
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Definition of generic strategies for the
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1
2
3
4
 
Figure 3: Schematic process for designing an 
integrated portfolio. 
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Each half of the proposed integrated portfolio is 
split into four quadrants: the dimension “market 
attractiveness” is divided by a hurdle growth rate, 
e.g. average sales growth or a sales growth target, 
the dimension “technology share” at a value of the 
relative technology share of 1, the “market share” 
dimension equally at a value of the relative market 
share of 1. 
In the case of a positioning in the same 
quadrant in both market and patent portfolio, the 
combined generic strategies remain appropriate: 
for a product with a star/star positioning, 
increased marketing and R&D expenditures are 
necessary to reinforce market and technological 
positions and to counter attacks from competitors.  
However, the generic strategies cannot be 
simply combined in case of disparate positionings. 
These could be interpreted as evidence for a 
misappropriation of R&D and/or marketing 
expenditures, but also simply result from industry 
specificities and thus not require any strategic 
action.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In all cases, the underlying situation has to be 
carefully evaluated in order to derive effective 
strategic implications from the portfolio analysis. 
An Application of  the Integrated 
Portfolio in the Chemical Industry 
A Data Collection and Measurements 
A first implementation of the proposed concept 
was carried out for two business units of a 
company operating in the specialty chemicals 
industry. For each unit, distinct product areas were 
defined. The entire analysis incorporates seven 
product fields and 22 products of Business Unit 1 
and three product fields and 15 products for 
Business Unit 2. Here, we can only report on some 
characteristic results. The required patent data 
were supplied by the firm’s patent department. 
Patent applications were assigned to product fields 
and individual products in a workshop with senior 
patenting experts from the company.  
 
Internal dimension 2: 
Technological position
Internal dimension1:
Market position
External dimension:
Market attractiveness
 
Figure 4: The integrated portfolio 
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The indicators described earlier required to 
draw patent portfolios had to be calculated. The 
share of granted patents was measured based on 
granted patents at the German Patent Office and 
international scope was calculated as the share of 
triad patents, filed in Europe, the US and Japan 
simultaneously, because it was believed by the 
experts from the patent department that this 
would best capture patent quality in this industry. 
Due to the very specialised nature of the business 
units’ products, no market growth rates and 
market share data were available. Thus, we had to 
rely on expert evaluations instead. The dimensions 
market attractiveness, relative market share and 
revenue share driving the circle size in the market 
portfolio were evaluated using a questionnaire sent 
out to marketing managers asking for their 
estimation of relative market share in relation to 
the strongest external competitor, product market 
growth relative to the average growth in the 
business unit and product sales relative to the 
average sales per product in the business unit.  
B Results of the Portfolio Analyses 
Based on these raw data, we constructed 
multiple portfolio visualisations on the business 
unit and product field levels. Please refer to figure 
5 for a sample portfolios. The visualisations were 
discussed in a joint meeting with marketing, R&D 
and patent managers from the company. Some of 
the discussion helps to better understand and 
interpret the portfolios. 
The analysis on the product area level (figure 5) 
draws a picture of a very attractive area, i.e., each 
product growing at least as fast as the business 
unit. In most cases, the products are positioned in 
corresponding quadrants of the portfolio. Thus, 
R&D and Marketing strategies are well aligned in 
these product areas. 
In some cases, however, there are obvious 
differences. Product 6 enjoys a strong market 
position in a high growth market. In contrast, its 
technology position is fairly weak.  
 
 
0
2
4
-0,25 0,25 0,75 1,25 1,750,75
Market Attractiveness
1,5
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Product 1Product 4
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Relative Technology ShareRelative market Share
 
Figure 5: The integrated portfolio: An application for a product area with six products (disguised). 
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This disparate positioning could be attributed 
to the fact that the company was still in the 
process of reinforcing its technological position 
and thus still intended to file for more patents. 
The need for further R&D investment in this 
product is clearly highlighted by the portfolio 
analysis and will be further emphasised by the 
company.  
Product 3 is characterised by a strong 
technological position and average numbers for 
market share and market growth. The company 
under consideration has a strong R&D emphasis 
on this product, however, the contribution to sales 
is rather modest. The discussion revealed that 
Marketing and R&D perceive the potential of the 
recently introduced product quite differently. It 
was decided to conduct a workshop with multiple 
company experts in order to reassess the 
attractiveness of this product. Based on the 
outcome a decision ought to be made whether 
R&D investments in this product should be 
realigned. The analysis at the business unit level 
follows a similar logic. 
In sum, the integrated portfolio analyses have 
shown that market and technology positions in the 
company under consideration are not always 
aligned. These results have led to a first discussion 
among company managers on the root causes for 
the observed inconsistencies of portfolio 
positions. This already highlights the need for 
intensive discussion based on the portfolio 
presentations before final conclusions are made. 
All managers perceived this to be very helpful to 
gain a common understanding of Marketing and 
R&D strategies. To get a more details picture and 
in order to incorporate further knowledgeable 
experts and decisions makers in the company, it 
was decided to carefully review the marketing, 
patenting and R&D strategies for some of the 
concerned areas. 
Conclusions  
The integrated portfolio can be a powerful tool 
for strategic planning purposes because it offers an 
efficient and effective way to better align 
Marketing and R&D strategies. The integrated 
portfolio combines a widely known and used 
market portfolio concept with a patent portfolio 
capturing technological aspects. Both portfolios’ 
dimensions, especially the abscissa, have been 
shown to impact business performance, thus 
making the portfolio illustrations especially 
meaningful for decision makers in firms. The clear 
focus on market orientation in the integrated 
portfolio as expressed on the ordinate where the 
integration of both portfolios is achieved by using 
the market portfolio’s initial dimension “market 
attractiveness”. It is believed that a technology’s 
attractiveness has to finally show on the market 
and that R&D strategies ought to be consequently 
aligned with market requirements (see 
introduction). In cases where market data is not 
yet available for new and future products, one 
should rely on accurate market forecasts derived 
from market research or other sources. Figure 6 
summarises the strategic implications which can be 
derived from the integrated portfolio. 
If both technology and products are placed in 
the same field of the market and technology 
portfolios represented by the combinations Aa, 
Bb, Cc and Dd in figure 6, the generic strategies 
from the separate portfolios can simply be added 
up and remain valid. The main advantage of our 
portfolio concept is the detection of disparate 
positionings. In the case example, we elaborated 
on the combinations Ab, Ba, Cd and Dc. In these 
cases, different generic strategies have to be 
applied and those from the separate portfolios 
might become invalid as demonstrated by our 
example. Several hypotheses can explain the 
differences and we tried to find some evidence in 
expert discussions. For a disparate positioning in 
the upper half of the portfolio, i.e. a high growth 
environment, a likely explanation for a strong 
technological position, but weak market position 
would be an insufficient satisfaction of market 
needs. In this case, R&D expenditure should be 
cut back as it cannot be earned back in the future. 
In contrast, it could also be possible that the weak 
market position is due to strong competition in the 
product market. This would call for larger 
investments in marketing, R&D investments 
simultaneously held constant or scaled up. In a low 
growth environment, our hypothesis explaining a 
differing position would be a misappropriation of 
R&D investments. As market “cash cows” usually 
require massive economies of scale to be 
profitable, aggressively building market share 
would be a loss-making strategy. The sustainability 
of a market “cash cow” could also be threatened 
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by a weak technological position. However, this 
need not be the case: if there are high barriers to 
entry due to economies of scale, the company does 
not need to protect its competitive position by 
property rights any more to prevent new firms 
from entering the market. We provided first 
evidence for possible strategic actions, which 
might be applied in these situations. However, it 
has to be stressed that these always need to be 
checked for appropriateness in the specific 
situation under evaluation. 
Another strength of the portfolio method is the 
visualisation of complex decision problems. It lays 
the ground for an intensive discussion of portfolio 
positions, their root causes and their implications. 
The case example clearly shows that the integrated 
portfolio establishes a framework for joint strategy 
discussions between technical and non-technical 
functions like R&D, Marketing and the Patent 
Department. 
We believe that the main benefit of portfolio 
techniques in strategic planning is the stimulation 
of cross-functional reviews of R&D and market 
strategy: as explained earlier in this chapter, there 
are hardly any combined generic strategies for 
disparate positionings which can be applied across 
industries and in different contexts. This opinion 
was confirmed by managers from the company, 
which found the portfolio very useful as a tool 
supporting strategic decision making.  
A further important benefit of the integrated 
concept is that further knowledge is created during 
the conceptualisation and implementation phases. 
The systematic condensation of patent data and 
the simultaneous visualisation of technology and 
products create a significant amount of knowledge. 
The analyses create a significant amount of 
important knowledge which separate portfolio 
analyses cannot provide.  
The limitations of this work can first be 
attributed to the case study approach, which is in a 
first step justified when new concepts are 
developed and preliminarily tested. A second 
limitation results from the data needed for the 
patent portfolio: if a company does not patent 
innovations, the method cannot be applied. 
However, patenting product innovations is a 
dominant strategy in many industries [37,47,48]. 
Thus, we do not believe that this severely limits 
the applicability of our approach in most cases. 
Finally, the proposed portfolio concept does not 
capture future technological developments which 
have not led to any patent applications yet. Here, 
traditional forecasting techniques, e.g. Delphi 
studies or scenario analysis, can be used which, 
however, have their own shortcomings [49,50]. 
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         Figure 6: Overview about partial generic strategies in the integrated portfolio. 
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